What is Janux Therapeutics's change in AR?

Janux Therapeutics (JANX) reported change in AR of $35M in Q1 2026.

What does change in AR mean?

Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.

Janux Therapeutics JANX Change in AR

Change in AR at other companies

Johnson & JohnsonJNJ

$595M-35.7%

AmgenAMGN

-$413M-132%

Regeneron PharmaceuticalsREGN

-$1.2M+99.8%

XencorXNCR

-$5.8M+75.2%

AbbVieABBV

-$87M-106%

CRISPR TherapeuticsCRSP

$0+100%

Other financials

Income statement

See full

Revenue$3.7M—

Operating income-$34.2M+2.0%

Net income-$24.4M-3.6%

EPS (diluted)-$0.39-2.6%

Balance sheet

See full

Cash & equivalents$51.8M-29.7%

Total debt$21.6M-4.6%

Total equity$941.5M-7.0%

Total assets$1.0B-2.1%

Cash flow

See full

Operating cash flow-$12.3M+27.5%

CapEx$273.0K-26.4%

Free cash flow-$12.6M+27.5%

Valuation

See full

Market cap$892.81M-36.3%

Enterprise value$862.55M-36.2%

P/S65×-85.2×

Profitability

See full

Operating margin-1,143.1%-65.1pp

Net margin-833.6%+0.9pp

FCF margin-571.6%+98.3pp

Returns & leverage

See full

Return on equity-11.7%+4.1pp

Debt / equity0×0.0×

Current ratio17×-41.5×

Where this comes from

Reported directly by Janux Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Janux Therapeutics's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Janux Therapeutics's change in AR?: Janux Therapeutics (JANX) reported change in AR of $35M in Q1 2026.
What does change in AR mean?: Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.